We investigated the involvement of 5-lipoxygenase activity in the earl
y phases of programmed cell death (PCD) induced by H2O2 or retinoids i
n different human tumour cells (erythroleukaemia, neuroblastoma, melan
oma). Apoptotic cells showed enhanced 5-lipoxygenase activity which wa
s paralleled by decreased superoxide dismutase activity and increased
light emission. Ultraweak luminescence, mainly due to membrane lipid p
eroxidation by lipoxygenase activation, increased in all cell lines te
sted within 10-15 min after induction of PCD, in a concentration and t
ime-dependent manner. At the same time, we observed a significant incr
ease in the intracellular steady state level of the 5-lipoxygenase met
abolite leukotriene B-4. Furthermore, 5-lipoxygenase metabolite 5-hydr
oxyeicosatetraenoic acid was able to induce PCD in all cell lines test
ed. Conversely, the general lipoxygenase inhibitor nordihydroguaiareti
c acid and the selective 5-lipoxygenase inhibitor caffeic acid protect
ed the different tumour cells from H2O2-induced PCD to a similar exten
t. These results show the activation of the 5-lipoxygenase pathway in
PCD of three different cancer cell lines.